Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0344 per EA under NDC 60687082001. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Dec 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
American Health PackagingNDC
60687082001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572FDA Approved
12/22/2017
TE Code
AB
On Market Since
9/14/2025
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 43 times since Dec 10, 2025, and over the history we have for it it has declined 19.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0344 per EA |
|---|---|
| All-time high | $0.0430 (Dec 10, 2025) |
| All-time low | $0.0328 (Jul 22, 2026) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0335 |
| Average price | $0.0351 |
| Largest weekly change | -9.4% (Jan 21, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by American Health Packaging, is $0.0344 per EA (NDC 60687082001), effective Sep 30, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 19.9%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Dec 10, 2025, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0328 (Jul 22, 2026) to a high of $0.0430 (Dec 10, 2025), with a median of $0.0335 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 41% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 60687082001) is labeled by American Health Packaging, and CMS classifies it as a generic product.